tweetindex
IT

BiopharmIQ by Amp ✓

@BiopharmIQ · PDUFA 🗓️ → · joined 20 Dec 2016

Catalyst Calendar, Big Mover stocks & model portfolios. Database & tools to help with your biotech investing & BD. not invstmnt advice. https://t.co/5njnanqtbK #biotech

29 927Followers
396Following
16 841Posts total
28.3KViews on collected posts

Ultimi post

Ready for Q4 2026 catalysts?! 👀 We’re tracking 88 Ph2 & Ph3 readout catalysts for Q4 2026 Before you reposition your portfolio, check what’s due. Build your watchlist before the headlines. 9/23 snapshot. Counts/timing may change. https://t.co/d2VlDXhmGW
2.6K views · 2 likes · 0 reposts · 1 replies Open on X →
📣 Join our Biotech Daily Stock Moves community... 📌 hottest headlines 🔥 📌 stock moves 📈📉 Stay informed and make smarter investing! Visit the link to join our community.👇 https://t.co/J93b6E1Q58 666 views · 1 likes · 0 reposts · 0 replies Open on X →
$ACIU +3% at open on positive Ph2 data for ACI-7104 in early Parkinson’s disease 📈 VacSYn Part 1: • Met all primary safety, tolerability & immunogenicity endpoints • 100% of treated patients developed antibodies after 3 immunizations What’s next? See the graphic and https://t.
2.2K views · 2 likes · 0 reposts · 1 replies Open on X →
Biotech Stock News 9/23 @ Open 2.4K views · 1 likes · 0 reposts · 0 replies Open on X →
$ANVS +3% at open after partnering with Weave Bio to support NDA preparation for buntanetap in Alzheimer’s. Which Alzheimer’s readouts are coming next? Build your watchlist before the headlines hit 👇 https://t.co/zonmh7ZvXj 360 views · 0 likes · 0 reposts · 0 replies Open on X →
Biotech Stock News 9/23 @ Open $SPRC 4% Enhancement of U.S. Patent Portfolio $ANVS 3% NDA preparation for Buntanetap $ACIU 3% ACI-7104 Safety & Immunogenicity Data $PHIO 1% Clinical Development Update & Catalysts $BCDA 1% Update on FDA and PMDA submissions $KAPA 1% Presenting at
5K views · 10 likes · 0 reposts · 2 replies Open on X →
$IONS FDA approves first treatment for Alexander disease, a rare brain disorder 🧠 Zanvastro (zilganersen) approved for pediatric and adult patients, from infancy through adulthood. • antisense oligonucleotide, reduces GFAP production • administered by spinal injection once http
4.6K views · 11 likes · 5 reposts · 1 replies Open on X →
More September PDUFAs ahead: $RARE | UX111, Sanfilippo syndrome | Sep 19 $MIRM | Zilurgisertib, FOP | Sep 26 $SRRK | Apitegromab, SMA | Sep 30 Get the FREE PDUFA report 👇 https://t.co/9x7pBtYVbb 4.1K views · 10 likes · 4 reposts · 0 replies Open on X →
IONS: 2 readouts today $IONS is down 2.75% to $60.71 today (-$1.72 vs. prior close of $62.43), according to BPIQ market data. • Eplontersen, Phase 3 CARDIO-TTRansform: The detailed ATTR-CM dataset confirmed the trial missed its overall primary endpoint. A nominally positive 6.4K views · 10 likes · 1 reposts · 3 replies Open on X →

Rispetto ad account della stessa dimensione

9 post degli ultimi 90 giorni, accanto alla fascia di 10K–100K follower. arriva a molti, ma pochi di loro reagiscono.

Visualizzazioni mediane2 571questo account924mediana per 10K–100K
Copertura, %8.59%questo account3.62%mediana per 10K–100K
Interazione, %0.15%questo account1.52%mediana per 10K–100K
MetricaQuesto accountMediana per 10K–100KRapporto
Visualizzazioni mediane per post2 5719242.78×
Copertura (visualizzazioni ÷ follower)8.59%3.62%2.37×
Tasso di interazione0.15%1.52%0.10×

Altri account di questa fascia →   Confronta con un altro account →   Come sono costruiti questi parametri →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

6.4K28 Aug
4.1K3 Sep
4.6K
5K23 Sep
360
2.4K
2.2K
666
2.6K

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.22%28 Aug
0.34%3 Sep
0.41%
0.26%23 Sep
0.00%
0.04%
0.14%
0.15%
0.12%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes64.4%47 in total
Reposts13.7%10 in total
Replies11.0%8 in total
Quotes4.1%3 in total
Bookmarks6.8%5 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Account simili